Cryoport, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Cryoport, Inc. on March 27, 2017, reporting events occurring through March 31, 2017. The filing details the completion of an underwritten public offering of common stock.
Key Financial Metrics
- Offering Size: 6,325,000 shares of common stock (including 825,000 shares from the full exercise of the underwriters' option).
- Offering Price: $2.00 per share.
- Net Proceeds: Approximately $11.5 million after deducting underwriting discounts, commissions, and estimated offering expenses.
- Revenue, Profit, and Cash Flow: The filing text does not provide specific values for revenue, profit, operating cash flow, margins, debt, or liquidity metrics.
Material Changes
The primary material change is the increase in equity capital and share count resulting from the public offering completed on March 31, 2017. The transaction was executed pursuant to an effective Form S-3 registration statement.
Outlook, Risks, and Unusual Items
The filing notes that certain underwriters (Cowen and Company, LLC and Needham & Company, LLC) and their affiliates have provided and may continue to provide commercial banking, financial advisory, and investment banking services to the Company for customary fees. No specific forward-looking guidance, risk factors, or unusual items were detailed in the text of this specific report beyond the standard disclosures regarding the offering.
Investor Verification Checklist
- Verify the final net proceeds received by the Company against the estimated $11.5 million.
- Review the full Underwriting Agreement (Exhibit 1.1) for lock-up periods and specific underwriter obligations.
- Confirm the updated total share count and diluted ownership structure post-offering.
- Examine the press releases (Exhibits 99.1 and 99.2) for management's stated use of proceeds.